Literature DB >> 14566455

Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability.

Carolina A M Schurink1, Christianne A Van Nieuwenhoven2, Jan A Jacobs2, Maja Rozenberg-Arska2, Hans C A Joore2, Erik Buskens2, Andy I M Hoepelman2, Marc J M Bonten2.   

Abstract

OBJECTIVE: Although quantitative microbiological cultures of samples obtained by bronchoscopy are considered the most specific tool for diagnosing ventilator-associated pneumonia, this labor-intensive invasive technique is not widely used. The Clinical Pulmonary Infection Score (CPIS), a diagnostic algorithm that relies on easily available clinical, radiographic, and microbiological criteria, could be an attractive alternative for diagnosing ventilator-associated pneumonia. Initially, the CPIS scoring system was validated upon 40 quantitative cultures of bronchoalveolar lavage fluid from 28 patients, and only few other studies have evaluated this scoring system since then. Therefore, little is known about the accuracy of this score.
DESIGN: We compared the scores of a slightly adjusted CPIS with results from quantitative cultures of bronchoalveolar lavage fluid in 99 consecutive patients with suspicion of ventilator-associated pneumonia, using growth of > or =10(4) cfu/ml in bronchoalveolar lavage fluid as a cut-off for diagnosing ventilator-associated pneumonia. In addition, the CPIS were calculated for 52 patients by two different intensivists to determine the inter-observer variability.
RESULTS: Ventilator-associated pneumonia was diagnosed in 69 (69.6%) patients. When using a CPIS >5 as diagnostic cutoff, the sensitivity of the score was 83% and its specificity was 17%. The area under the Receiver Operating Characteristic curve was 0.55. The level of agreement for prospectively measured Clinical Pulmonary Infection Score (< or =6 and >6) was poor (kappa =0.16).
CONCLUSIONS: When compared to quantitative cultures of bronchoalveolar lavage fluid, the CPIS has a low sensitivity and specificity for diagnosing ventilator-associated pneumonia with considerable inter-observer variability.

Entities:  

Mesh:

Year:  2003        PMID: 14566455     DOI: 10.1007/s00134-003-2018-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  19 in total

Review 1.  The prevention of ventilator-associated pneumonia.

Authors:  M H Kollef
Journal:  N Engl J Med       Date:  1999-02-25       Impact factor: 91.245

2.  Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited.

Authors:  Muriel Fartoukh; Bernard Maitre; Stephanie Honoré; Charles Cerf; Jean-Ralph Zahar; Christian Brun-Buisson
Journal:  Am J Respir Crit Care Med       Date:  2003-05-08       Impact factor: 21.405

3.  Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial.

Authors:  J Pugin; R Auckenthaler; D P Lew; P M Suter
Journal:  JAMA       Date:  1991 May 22-29       Impact factor: 56.272

4.  Diagnostic techniques for ventilator-associated pneumonia.

Authors:  J E Fischer; M Janousek; D Nadal; S Fanconi
Journal:  Lancet       Date:  1998-09-26       Impact factor: 79.321

Review 5.  The diagnosis of pneumonia in the critically ill.

Authors:  C S Garrard; C D A'Court
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

6.  Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture.

Authors:  C H A'Court; C S Garrard; D Crook; I Bowler; C Conlon; T Peto; E Anderson
Journal:  Q J Med       Date:  1993-10

7.  Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia.

Authors:  J Chastre; J Y Fagon
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

8.  Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies.

Authors:  N Fàbregas; S Ewig; A Torres; M El-Ebiary; J Ramirez; J P de La Bellacasa; T Bauer; H Cabello
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

9.  Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid.

Authors:  J Pugin; R Auckenthaler; N Mili; J P Janssens; P D Lew; P M Suter
Journal:  Am Rev Respir Dis       Date:  1991-05

10.  Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

Authors:  Jan Hayon; Corinne Figliolini; Alain Combes; Jean-Louis Trouillet; Najibi Kassis; Marie Christine Dombret; Claude Gibert; Jean Chastre
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

View more
  48 in total

1.  The occurrence of pneumonia diagnosis among neurosurgical patients: the definition matters.

Authors:  Petri Kuusinen; Tero Ala-Kokko; Airi Jartti; Lauri Ahvenjarvi; Pirjo Saynajakangas; Pasi Ohtonen; Hannu Syrjala
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

2.  A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia.

Authors:  Addison K May; Jacob S Brady; Joann Romano-Keeler; Wonder P Drake; Patrick R Norris; Judith M Jenkins; Richard J Isaacs; Erik M Boczko
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

3.  Rethinking pneumonia: A paradigm shift with practical utility.

Authors:  Rishi Chanderraj; Robert P Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

4.  Review article: ventilator-associated pneumonia in major burns.

Authors:  A D Rogers; A C Argent; H Rode
Journal:  Ann Burns Fire Disasters       Date:  2012-09-30

5.  Ventilator-associated conditions versus ventilator-associated pneumonia: different by design.

Authors:  Michael Klompas
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

6.  Kinetic therapy in multiple trauma patients with severe thoracic trauma: a treatment option to reduce ventilator time and improve outcome.

Authors:  S Wutzler; K Sturm; T Lustenberger; H Wyen; K Zacharowksi; I Marzi; T Bingold
Journal:  Eur J Trauma Emerg Surg       Date:  2016-06-06       Impact factor: 3.693

7.  Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.

Authors:  Boris Jung; Nathalie Embriaco; François Roux; Jean-Marie Forel; Didier Demory; Jérôme Allardet-Servent; Samir Jaber; Bernard La Scola; Laurent Papazian
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

8.  A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.

Authors:  John M Boyce; Olivia-Fabiola Pop; Odaliz Abreu-Lanfranco; Whitney Y Hung; Ann Fisher; Afshin Karjoo; Benjamin Thompson; Zenon Protopapas
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

9.  Reliability of the medication appropriateness index in Dutch residential home.

Authors:  Clementine C M Stuijt; Eric J F Franssen; Antoine C G Egberts; Stephen A Hudson
Journal:  Pharm World Sci       Date:  2009-03-12

10.  Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report.

Authors:  Pierre Emmanuel Charles; Emmanuel Kus; Serge Aho; Sébastien Prin; Jean-Marc Doise; Nils-Olivier Olsson; Bernard Blettery; Jean-Pierre Quenot
Journal:  BMC Infect Dis       Date:  2009-04-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.